Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Affymetrix and the Centre for Proteomic and Genomic Research (CPGR) have signed a deal to advance genomics research and personalized medicine studies in South Africa.
Subscribe to our email newsletter
The CPGR will leverage Affymetrix GeneTitan multi-channel (MC) instrument to offer gene expression and Axiom genotyping services to researchers in the region.
CPGR Managing Director Dr Reinhard Hiller said, "The high throughput capability of GeneTitan® MC Instrument combined with customizable Axiom Genotyping Arrays is ideal for meeting the needs of scientists in Africa whose research projects range from small pilot to large-scale discovery to focused validation studies."
GeneTitan MC Instrument when integrated with Axiom Genotyping Arrays is expected to expand the genomics service capabilities and enable disease-related biomarker discovery.
Affymetrix international markets commercial operations VP Chris Barbazette said, "Affymetrix is leading the way in population optimized genotyping analysis and was the first to create a genotyping array with content derived specifically from African populations."